Aveanna Healthcare AVAH
- Market cap
- $2.9B
- PE
- 10.9×
- 1y median 21.8×
- Forward PE
- n/m
- not a meaningful number
- Price to sales
- 1.1×
- EV/EBIT
- 14.6×
- Revenue, 12 months
- $2.6B
- +20% on a year ago
- Net margin
- 10.6%
- Free cash flow yield
- 5.4%
Aveanna Healthcare trades at 10.9× trailing earnings, near its ten-year median. Revenue was $2.6B over the last twelve months, up 20% on a year earlier with a 11% net margin.
Charts
Financials
| Income statement | Q3 FY23 | Q4 FY23 | Q1 FY24 | Q2 FY24 | Q3 FY24 | Q4 FY24 | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $478M+8% | $478.8M+6% | $490.7M+5% | $505M+7% | $509M+7% | $519.9M+9% | $559.2M+14% | $589.6M+17% | $621.9M+22% | $662.5M+27% | $647.9M+16% | $670.5M+14% | |
| Cost of revenue | $330.7M+7% | $330.4M+3% | $344.8M+7% | $346.7M+10% | $349.3M+6% | $348.1M+5% | $375.7M+9% | $378.8M+9% | $419.1M+20% | $449.2M+29% | $442.5M+18% | $452M+19% |
| Gross profit | $147.3M+9% | $148.4M+15% | $145.9M+1% | $158.3M+2% | $159.7M+8% | $171.7M+16% | $183.6M+26% | $210.8M+33% | $202.8M+27% | $213.3M+24% | $205.4M+12% | $218.5M+4% |
| SG&A | $91M+2% | $87M−3% | $87.9M−4% | $88M−4% | $88.2M−3% | $88.7M+2% | $91.4M+4% | $90.1M+2% | $95.4M+8% | $97.6M+10% | $95.8M+5% | $97.1M+8% |
| −$76.4M | $29.3M | $22.9M+30% | $37.1M−1% | $34M | $45.8M+56% | $51.8M+127% | $80M+116% | $53.6M+58% | $71M+55% | $69.3M+34% | $80M−0% | |
| Interest expense | $39.6M+39% | $39.7M+17% | $39.6M+10% | $39.6M+4% | $39.2M−1% | $38.1M−4% | $36.3M−8% | $36M−9% | $35.1M−11% | $32.6M−14% | $29.2M−20% | $27.8M−23% |
| Pre-tax income | −$101.8M | −$31.6M−87% | $1.5M | $4M−84% | −$27.3M−73% | $26.9M | $10.1M+581% | $44.1M+1009% | $13.4M | $39.2M+46% | $45M+343% | $56.5M+28% |
| $631K | −$5.9M+330% | $12.7M+709% | −$9.9M+1126% | $15.5M+2358% | −$2.2M−62% | $5M−61% | $17.1M | −$647K | −$139.5M+6114% | $3.3M−33% | $16.2M−6% | |
| Net income | −$102.4M | −$25.7M−89% | −$11.2M−65% | $13.9M−46% | −$42.8M−58% | $29.2M | $5.2M | $27M+94% | $14.1M | $178.8M+513% | $41.7M+702% | $40.3M+49% |
| −$0.54 | −$0.13−90% | −$0.06−65% | $0.07−46% | −$0.22−59% | $0.15 | $0.03 | $0.13+86% | $0.06 | $0.80+433% | $0.19+533% | $0.18+39% | |
| 189.1M+2% | 190.9M+3% | 192.2M+2% | 196.9M+4% | 193.4M+2% | 193.4M+1% | 206.2M+7% | 210.4M+7% | 222.2M+15% | 223.5M+16% | 222.1M+8% | 224.9M+7% |
Gross profit: 26 periods, Q1 FY20 to Q2 FY26: not printed by the filing, worked out from its own lines.
EPS, diluted: 6 periods, Q4 FY20 to Q4 FY25: quarter's net income to common over its shares, to the cent.
Diluted shares: 4 periods, Q4 FY20 to Q4 FY23: a loss quarter: its basic count, share-days: the 12-month average less the 9-month, weighted by days. Q4 FY24 and Q4 FY25: share-days: the 12-month average less the 9-month, weighted by days.
From each company's 10-Q and 10-K filings, the newest version of each figure. Quarters are as filed (a fourth quarter is the year less its first nine months), fiscal years as the 10-K prints them, restated where a later 10-K restated them, and balance sheet lines as of the period's end. A quarter whose 10-Q isn't filed yet is from the company's results release. Growth is on the same period a year earlier. A dash is a period with no figure for the line: the filing doesn't print it, or it hasn't been read yet.
Peers
Companies in Medical - Care Facilities nearest Aveanna Healthcare's size, closest first.
| Company | Market cap | PE | Its 10y median PE | Fwd PE | P/S | Revenue growth | Net margin |
|---|---|---|---|---|---|---|---|
| AVAHAveanna Healthcare | $2.9B | 10.9× | 21.8× | 1.1× | +20% | 10.6% | |
| PRVAPrivia Health | $2.9B | 107× | 158× | 1.2× | +24% | 1.2% | |
| MDPediatrix Medical | $2.4B | 14.0× | 13.4× | 1.2× | +1% | 9.0% | |
| NHCNational Healthcare | $3.7B | 26.5× | 21.4× | 2.4× | +7% | 9.0% | |
| ADUSAddus HomeCare | $2.3B | 21.4× | 32.4× | 1.5× | +16% | 7.1% | |
| PGNYProgyny | $2.2B | 31.5× | 55.1× | 1.7× | +6% | 6.0% | |
| OPCHOption Care Health | $4.7B | 23.5× | 26.4× | 0.8× | +6% | 3.7% | |
| HCSGHealthcare Services | $1.7B | 14.7× | 26.1× | 0.9× | +4% | 6.6% | |
| ARDTArdent Health | $1.7B | 22.3× | 8.5× | 0.3× | +3% | 1.2% | |
| LFSTLifeStance Health | $4.9B | 99.5× | 142× | 3.1× | +20% | 3.2% | |
| CONConcentra Group Holdings Parent | $5B | 25.5× | 17.5× | 2.2× | +14% | 8.7% | |
| Peer median | $2.6B | 24.5× | 26.3× | 1.4× | +6% | 6.3% |
More on Aveanna Healthcare
Each number over time
- PE ratio
- Price to sales ratio
- EV/EBIT
- Price to free cash flow
- Price to book ratio
- Market cap
- Revenue
- EPS
- Free cash flow
- Profit margin
- Shares outstanding
Where it ranks
- #5of 42Hospital and care facility stocks with the highest profit margins
- #3of 25Hospital and care facility stocks with the lowest PE ratio
Its groups
About
- Industry
- Medical - Care Facilities
- Sector
- Healthcare
Valuation data, not investment advice. Prices as of .